(Q38181037)

English

Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction

scientific article published on 11 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 August 2017

0 references

Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction (English)

1 reference

Europe PubMed Central

30 August 2017

1 reference

based on heuristic

inferred from title

object named as

Ingrid Hopper

3

0 references

2

object named as

Henry Krum

1 reference

Europe PubMed Central

30 August 2017

author name string

Hannah Clark

1

1 reference

Europe PubMed Central

30 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

11 December 2013

1 reference

Europe PubMed Central

30 August 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

30 August 2017

16

1 reference

Europe PubMed Central

30 August 2017

1

1 reference

Europe PubMed Central

30 August 2017

41-48

1 reference

Europe PubMed Central

30 August 2017

Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Renal impairment and outcomes in heart failure: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH).

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study).

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Stud

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Renal function, health outcomes, and resource utilization in acute heart failure: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Interaction revisited: the difference between two estimates

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CH

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Cardiorenal syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Sympatho-renal axis in chronic disease

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Worsening kidney function in decompensated heart failure: treat the heart, don't mind the kidney

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

21 January 2018

Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of renin and prorenin in heart failure patients with decreased kidney function

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.13

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJHF.13

1 reference

Europe PubMed Central

30 August 2017

1 reference

Europe PubMed Central

30 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38181037&oldid=2149062510"